ID   JR
AC   CVCL_RT33
DR   cancercelllines; CVCL_RT33
DR   Cell_Model_Passport; SIDM01584
DR   Cosmic; 1718363
DR   Cosmic; 2356032
DR   DepMap; ACH-001096
DR   PRIDE; PXD039480
DR   Wikidata; Q54899054
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=36768928;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Deep exome analysis.
CC   Omics: Cell surface proteome.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 12
//
RX   PubMed=22142829; DOI=10.1158/1078-0432.CCR-11-2056;
RA   Shukla N., Ameur N., Yilmaz I., Nafa K., Lau C.-Y., Marchetti A.,
RA   Borsu L., Barr F.G., Ladanyi M.;
RT   "Oncogene mutation profiling of pediatric solid tumors reveals
RT   significant subsets of embryonal rhabdomyosarcoma and neuroblastoma
RT   with mutated genes in growth signaling pathways.";
RL   Clin. Cancer Res. 18:748-757(2012).
//
RX   PubMed=23665679; DOI=10.1038/onc.2013.129;
RA   Sokolowski E., Turina C.B., Kikuchi K., Langenau D.M., Keller C.;
RT   "Proof-of-concept rare cancers in drug development: the case for
RT   rhabdomyosarcoma.";
RL   Oncogene 33:1877-1889(2014).
//
RX   PubMed=36768928; DOI=10.3390/ijms24032601;
RA   Timpanaro A., Piccand C., Uldry A.-C., Bode P.-K., Dzhumashev D.,
RA   Sala R., Heller M., Rossler J., Bernasconi M.;
RT   "Surfaceome profiling of cell lines and patient-derived xenografts
RT   confirm FGFR4, NCAM1, CD276, and highlight AGRL2, JAM3, and L1CAM as
RT   surface targets for rhabdomyosarcoma.";
RL   Int. J. Mol. Sci. 24:2601.1-2601.28(2023).
//